Bovine Hypothalamus
Also known as: Bovine hypothalamus extract, Cattle hypothalamus, Hypothalamus extract, Bovine Hypothalamus Extract
Overview
Bovine hypothalamus extract is derived from the hypothalamus of cattle (Bos taurus) and contains bioactive peptides and growth factors, including fibroblast growth factor (FGF)-like mitogens and endothelial cell growth factors. Historically, it has been investigated for its potential mitogenic and growth-promoting activities in cell culture and animal models. However, its use in human supplementation is not common, and research remains primarily preclinical. The extract's key characteristic is its in vitro mitogenic activity, although this effect has not been consistently demonstrated in human endothelial cells. The current research maturity level is early-stage, with limited human clinical trials and a low quality of available evidence, primarily consisting of in vitro and animal studies. Therefore, there are no systematic reviews or meta-analyses on human supplementation to support its use.
Benefits
Currently, there are no well-established benefits of bovine hypothalamus extract in humans due to the lack of robust clinical trials. In vitro studies have shown that bovine hypothalamus extracts can stimulate cell proliferation in Swiss 3T3 cells and, to a lesser extent, in human umbilical vein endothelial cells. However, these findings have not been translated into statistically significant clinical outcomes in humans. There are no documented secondary effects or population-specific benefits. Consequently, effect sizes and clinical significance cannot be determined due to the absence of human clinical data. The time course of any potential benefits is also not established.
How it works
Bovine hypothalamus extract is believed to exert its effects through mitogenic activity mediated by FGF-like and endothelial cell growth factors. These growth factors interact with fibroblast growth factor receptors and endothelial cell receptors, potentially stimulating cell proliferation. However, the systemic effects in vivo are unclear. The oral absorption and bioavailability of the large peptides and proteins present in the extract have not been studied in humans, but are generally expected to be low, which may limit its effectiveness when taken orally.
Side effects
Due to insufficient data, the safety profile of bovine hypothalamus extract in humans is not well-defined. Common, uncommon, and rare side effects have not been reported in the available literature. Drug interactions have not been studied, and contraindications are not established. Special population considerations have also not been investigated. Therefore, a comprehensive safety assessment is not possible at this time, and caution is advised.
Dosage
There are no established dosing guidelines for bovine hypothalamus extract due to the lack of human studies. Minimum effective dose, optimal dosage ranges, and maximum safe dose have not been determined. Timing considerations and form-specific recommendations are also not available. The oral absorption of large peptides and proteins is generally poor, which may affect dosage considerations if taken orally. Required cofactors have not been studied. Therefore, specific dosage recommendations cannot be provided.
FAQs
Is there evidence to support the use of bovine hypothalamus as a supplement in humans?
No, there is currently no evidence to support the use of bovine hypothalamus as a supplement in humans. Research is limited to in vitro and animal studies.
Is bovine hypothalamus extract safe?
Safety data are lacking for bovine hypothalamus extract in humans, and its use is not recommended without further research.
What are the expected results from taking bovine hypothalamus extract?
Based on current evidence, there are no expected benefits from taking bovine hypothalamus extract as a supplement.
What is the misconception about bovine hypothalamus?
A common misconception is that bovine hypothalamus extracts have proven benefits for human health, but current evidence is limited to in vitro and animal studies.
Research Sources
- https://pubmed.ncbi.nlm.nih.gov/32276466/ – This in vitro study demonstrated that bovine hypothalamus extracts contain FGF-like and endothelial cell growth factors with mitogenic activity in Swiss 3T3 cells. However, the mitogenic activity was not consistently observed in human umbilical vein endothelial cells, suggesting potential species-specific effects. The study highlights the need for further research to understand the effects of these extracts in human systems.
- https://pubmed.ncbi.nlm.nih.gov/293671/ – This research investigates growth factors present in the bovine hypothalamus. It identifies and characterizes several mitogens, including FGF-like substances, that stimulate cell proliferation. The study provides a foundation for understanding the potential mechanisms of action of bovine hypothalamus extracts, but does not address clinical applications or safety in humans.
- https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2021.687923/full – This article explores the potential of hypothalamus-derived products in veterinary medicine. It discusses the role of hypothalamic peptides in regulating various physiological functions and their potential therapeutic applications. While the focus is on veterinary science, it provides insights into the broader context of hypothalamus extracts and their potential uses.
- https://journals.physiology.org/doi/10.1152/ajpregu.00186.2024 – This study investigates the role of the hypothalamus in regulating various physiological functions. It provides insights into the complex interactions between the hypothalamus and other body systems. While not directly focused on bovine hypothalamus extracts, it offers valuable background information on the functions of the hypothalamus.
- https://academic.oup.com/nutritionreviews/article/83/3/e1259/7716583 – This review article discusses the role of various nutrients and dietary factors in brain health. It provides a broad overview of the impact of nutrition on cognitive function and neurological disorders. While not specifically addressing bovine hypothalamus, it offers a context for understanding the potential role of dietary factors in brain health.
Supplements Containing Bovine Hypothalamus
Recommended Articles

Ashwagandha for Stress: Clinical Evidence
Clinical trials support ashwagandha's efficacy in reducing stress and anxiety, with minimal side effects when taken in recommended dosages.

Ashwagandha for Anxiety: 2024-2025 Research Insights
Recent trials show ashwagandha significantly reduces anxiety symptoms with a recommended dosage of 300-500mg twice daily.